Paion (Germany)

Recent papers from Paion (Germany)

1. Transfer of Intravenous Remimazolam into Milk of Lactating Sheep and Uptake by Breast-fed LambsCurrent Drug Metabolism · 2025
2. Benefits and Challenges for Decentralized Use of Biomass as Feedstock for ChemicalsChemie Ingenieur Technik · 2025
3. Development and analysis of a remimazolam pharmacokinetics and pharmacodynamics model with proposed dosing and concentrations for anaesthesia and sedationBritish Journal of Anaesthesia · 2025
4. Angiotensin II for Catecholamine Resistant Vasodilatory Shock in Patients with Acute Kidney Injury: A Post-Hoc Analysis of the ATHOS-3 TrialShock · 2024
5. Carboxylesterase 1-Based Drug-Drug Interaction Potential of Remimazolam: In-Vitro Studies and Literature ReviewCurrent Drug Metabolism · 2024
6. Drug-Drug Interaction Potential of Remimazolam: CYP 450, Transporters, and Protein BindingCurrent Drug Metabolism · 2024
7. The Metabolism of the New Benzodiazepine RemimazolamCurrent Drug Metabolism · 2024
8. Target-controlled Infusion of Remimazolam in Healthy Volunteers Shows Some Acute ToleranceAnesthesiology · 2023
9. Efficacy of remimazolam versus midazolam for procedural sedation: post hoc integrated analyses of three phase 3 clinical trialsEndoscopy International Open · 2022
10. Standardization and Control of Grignard Reactions in a Universal Chemical Synthesis Machine using online NMRENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2021
11. Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairmentBritish Journal of Anaesthesia · 2021
12. Correlation of Vital Signs and Depth of Sedation by Modified Observer’s Assessment of Alertness and Sedation (MOAA/S) Scale in BronchoscopyJournal of Bronchology & Interventional Pulmonology · 2021
13. Safety and efficacy of remimazolam in high risk colonoscopy: A randomized trialDigestive and Liver Disease · 2020
14. Pharmacokinetics and pharmacodynamics of intranasal remimazolam—a randomized controlled clinical trialEuropean Journal of Clinical Pharmacology · 2020
15. Remimazolam Has Low Oral Bioavailability and No Potential for Misuse in Drug-Facilitated Sexual Assaults, with or Without Alcohol: Results from Two Randomised Clinical TrialsDrugs in R&D · 2020
16. Randomized Crossover Trial to Compare Abuse Liability of Intravenous Remimazolam Versus Intravenous Midazolam and Placebo in Recreational Central Nervous System Depressant UsersThe Journal of Clinical Pharmacology · 2020
17. Potential strategy for assessing QT/QTc interval for drugs that produce rapid changes in heart rate: Electrocardiographic assessment of the effects of intravenous remimazolam on cardiac repolarizationBritish Journal of Clinical Pharmacology · 2020
18. Time‐to‐Event Modeling for Remimazolam for the Indication of Induction and Maintenance of General AnesthesiaThe Journal of Clinical Pharmacology · 2020
19. Metabolism of remimazolam in primary human hepatocytes during continuous long-term infusion in a 3-D bioreactor systemDrug Design Development and Therapy · 2019
20. F376A/M388A‐solulin, a new promising antifibrinolytic for severe haemophilia AHaemophilia · 2016